PULSION Medical Systems SE announced consolidated earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported sales were EUR 8.955 million against EUR 9.454 million a year ago. EBITDA was EUR 2.872 million against EUR 3.151 million a year ago. EBIT was EUR 2.396 million against EUR 2.751 million a year ago. Group net profit attributable to shareholders of the group parent company was EUR 882 million against EUR 1.838 million a year ago. Earnings per diluted share were EUR 0.11 against EUR 0.22 a year ago. Cash flow from operating activities after changes in net working capital was EUR 2.870 million against EUR 1.036 million a year ago. Operating profit was EUR 2.415 million against EUR 2.722 million a year ago. Profit before taxes (EBT) was EUR 2.404 million against EUR 2.766 million a year ago. Acquisition of purchased and internally generated intangible assets was EUR 211 million against EUR 174 million a year ago. Purchase of property, plant and equipment (without monitors) was EUR 24 million against EUR 142 million a year ago.

For 2014, the company forecast a sales increase in the range of 4% - 6%. This growth is based on expectations, that mutual distribution agreements with the Getinge Group can be closed in the second quarter over the distribution of several product lines in different regions. At the level of the operating result, the company forecast an EBIT margin ­ adjusted for exceptional items ­ within a range of 26% - 28%.